Sirsendu Sekhar Ray1, Krishna Pramanik2, Sunil Kumar Sarangi3, Nirved Jain4. 1. Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, 769008, India. 2. Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, 769008, India. kpr@nitrkl.ac.in. 3. Department of Mechanical Engineering, National Institute of Technology, Rourkela, 769008, India. 4. Jeevan Memorial Hospital, Raipur, India.
Abstract
OBJECTIVE: To develop a cost-effective, non-toxic and xeno-free freezing solution for the preservation of adipose tissue-derived stem cells (hADSC) with a long shelf-life. RESULTS: The potential of various hydrocolloids and organic osmolytes as cryoprotectants and individual components of phosphate buffered saline (PBS) as carrier media were evaluated to formulate a freezing solution for the cryopreservation of hADSCs. Among the hydrocolloids, the highest viability, 55 %, was achieved with post-thawed (after 48 h storage at -80 °C) hADSCs cryopreserved in 10 % (v/v) polyvinylpyrrolidone (PVP) using PBS as carrier media. 0.9 % NaCl was a superior carrier medium resulting an enhanced cell viability (70 %) when used in 10 % PVP than other components of PBS. A higher cell viability (81 %) was achieved when 10 % PVP/0.9 % NaCl was supplemented with 60 mM ectoin. The cryopreserved cells retained normal cytoskeletal distribution pattern and adipogenic and osteogenic differentiation ability during 14 and 21 days of incubation. CONCLUSION: A serum-free and non-toxic 10 % PVP/0.9 % NaCl/60 mM ectoin freezing solution was developed for cryopreservation of hADSC for application in tissue engineering and regenerative medicine.
OBJECTIVE: To develop a cost-effective, non-toxic and xeno-free freezing solution for the preservation of adipose tissue-derived stem cells (hADSC) with a long shelf-life. RESULTS: The potential of various hydrocolloids and organic osmolytes as cryoprotectants and individual components of phosphate buffered saline (PBS) as carrier media were evaluated to formulate a freezing solution for the cryopreservation of hADSCs. Among the hydrocolloids, the highest viability, 55 %, was achieved with post-thawed (after 48 h storage at -80 °C) hADSCs cryopreserved in 10 % (v/v) polyvinylpyrrolidone (PVP) using PBS as carrier media. 0.9 % NaCl was a superior carrier medium resulting an enhanced cell viability (70 %) when used in 10 % PVP than other components of PBS. A higher cell viability (81 %) was achieved when 10 % PVP/0.9 % NaCl was supplemented with 60 mM ectoin. The cryopreserved cells retained normal cytoskeletal distribution pattern and adipogenic and osteogenic differentiation ability during 14 and 21 days of incubation. CONCLUSION: A serum-free and non-toxic 10 % PVP/0.9 % NaCl/60 mM ectoin freezing solution was developed for cryopreservation of hADSC for application in tissue engineering and regenerative medicine.
Authors: Juhi Sharma; Jeffrey M Hampton; Giancarlo R Valiente; Takuma Wada; Holly Steigelman; Matthew C Young; Rachel R Spurbeck; Alisa D Blazek; Steffi Bösh; Wael N Jarjour; Nicholas A Young Journal: Front Immunol Date: 2017-05-10 Impact factor: 7.561
Authors: Tae Hoon Jang; Sung Choel Park; Ji Hyun Yang; Jung Yoon Kim; Jae Hong Seok; Ui Seo Park; Chang Won Choi; Sung Ryul Lee; Jin Han Journal: Integr Med Res Date: 2017-01-10
Authors: Gina D Kusuma; Mehri Barabadi; Jean L Tan; David A V Morton; Jessica E Frith; Rebecca Lim Journal: Front Pharmacol Date: 2018-10-29 Impact factor: 5.810